Currently Viewing:
Newsroom
Currently Reading
Payers Have Room for Improvement in Delivering Pain Care, Study Says
June 22, 2018 – Allison Inserro
5 Things to Know About the CREATES Act
June 22, 2018 – Kelly Davio
AJMC® in the Press, June 22, 2018
June 22, 2018 – AJMC Staff
What We're Reading: Health Agencies Could Change; Pandemic Gaps Highlighted; Cigna Seeks to Cut Overdoses
June 22, 2018 – AJMC Staff
Study Compares Cannabis Benefits for Patients With Chronic Pain and Migraine
June 22, 2018 – Alison Rodriguez
Patients With Myelofibrosis Treated With JAK1/2 Inhibitors at Increased Risk of Lymphomas
June 22, 2018 – Laura Joszt
Neurofilament Light Prevalence Predicts Disease Progression in RRMS
June 21, 2018 – Samantha DiGrande
Tracking Medicaid Expansion
June 21, 2018 – AJMC Staff
FDA Warns Efficacy Concerns in Some Patients Taking Keytruda, Tecentriq
June 21, 2018 – Samantha DiGrande

AJMC® in the Press, January 12, 2018

AJMC Staff
Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press.
Modern Medicine’s article on antibiotic stewardship programs cited a study published in The American Journal of Managed Care® (AJMC®) when discussing the value of the programs. The study, “Improving Antibiotic Stewardship: A Stepped-Wedge Cluster Randomized Trial,” found that using computer alerts to inform doctors when antibiotics may not be the best course of treatment led to a 22% improvement in the odds of prescribing antibiotics. The authors concluded that clinical decision software integrated in an electronic health record can discourage inappropriate antibiotic prescribing and will likely change diagnostic patterns.

Another Modern Medicine article centered on the AJMC®-published article, “The Role of Direct Oral Anticoagulants in the Management of Venous Thromboembolism.” The article reported that, compared with warfarin, direct oral anticoagulants (DOACs) provide a more predictable anticoagulant response, fewer drug interactions, significantly less risk of hemorrhagic stroke, no monitoring requirements, and short half-lives. However, there are many patients for whom DOACs are not suitable. According to the author, patients with liver disease, coagulopathy, severe kidney disease, or cancer should not receive DOACs.

 
Copyright AJMC 2006-2018 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome the the new and improved AJMC.com, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up
×

Sign In

Not a member? Sign up now!